Regulatory Considerations for Using Artificial Intelligence Models to Reduce Sample Sizes in Registrational Studies

Aaron M. Smith, Tala Fakhouri, Run Zhuang +1

Applications of artificial intelligence (AI) in drug development continue to increase at a rapid pace. Regulatory authorities have provided increasingly clear perspectives on the u…